Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heinemann

Showing results (171-180 of 172) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 172 results.
Frontiers in Immunology|June 25, 2026
Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus reportStefan Reuter, Louise Benning, Andrea Dick, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 20, 2019
Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter StudyMalte Ziemann, Wolfgang Altermann, Katharina Angert, et al.
Pageof 18

Showing results (171-180 of 172) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 172 results.
Frontiers in Immunology|June 25, 2026
Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus reportStefan Reuter, Louise Benning, Andrea Dick, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 20, 2019
Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter StudyMalte Ziemann, Wolfgang Altermann, Katharina Angert, et al.
Pageof 18